CD8(+) T cells regulate immune responses in a murine model of allergen-induced sensitization and airway inflammation
- PMID: 15214030
- DOI: 10.1002/eji.200324623
CD8(+) T cells regulate immune responses in a murine model of allergen-induced sensitization and airway inflammation
Abstract
The role of CD8(+) T cells in the development of allergic airway disease is controversial. On the one hand, CD8(+) T cells are known to inhibit the development of airway hyperreactivity (AHR) in murine models of asthma. In humans, IL-10-producing CD8(+) T cells were shown to act as regulatory cells, inhibiting both proliferation and cytokine secretion of T cells. On the other hand, CD8(+) T cells can promote IL-5-mediated eosinophilic airway inflammation and the development of AHR in animal models. To examine this, we investigated the role of CD8(+) T cells during the induction of allergen-induced AHR and demonstrated a protective effect of CD8(+) T cells. Depletion of CD8(+) T cells prior to the immunization led to increased Th2 responses and increased allergic airway disease. However, after development of AHR, CD8(+) T cells that infiltrated the lungs secreted high levels of IL-4, IL-5 and IL-10, but little IFN-gamma, whereas CD8(+) T cells in the peribronchial lymph nodes or spleen produced high levels of IFN-gamma, but little or no Th2 cytokines. These data demonstrate protective effects of CD8(+)T cells against the induction of immune responses and show a functional diversity of CD8(+) T cells in different compartments of sensitized mice.
Similar articles
-
CD8+ T cell contributions to allergen induced pulmonary inflammation and airway hyperreactivity.Eur J Immunol. 2005 Jul;35(7):2061-70. doi: 10.1002/eji.200425715. Eur J Immunol. 2005. PMID: 15948214
-
Transfer of the enhancing effect of respiratory syncytial virus infection on subsequent allergic airway sensitization by T lymphocytes.J Immunol. 1999 Nov 15;163(10):5729-34. J Immunol. 1999. PMID: 10553105
-
Effector CD8+ T cells mediate inflammation and airway hyper-responsiveness.Nat Med. 2004 Aug;10(8):865-9. doi: 10.1038/nm1081. Epub 2004 Jul 18. Nat Med. 2004. PMID: 15258576
-
CD8+ T cells in asthma: friend or foe?Pharmacol Ther. 2009 Feb;121(2):123-31. doi: 10.1016/j.pharmthera.2008.09.001. Epub 2008 Oct 1. Pharmacol Ther. 2009. PMID: 18940198 Review.
-
Immune tolerance and protection against allergic sensitization.Allergy. 1995;50(25 Suppl):34-6. doi: 10.1111/j.1398-9995.1995.tb04274.x. Allergy. 1995. PMID: 7677232 Review.
Cited by
-
The innate immune brakes of the lung.Front Immunol. 2023 Jan 27;14:1111298. doi: 10.3389/fimmu.2023.1111298. eCollection 2023. Front Immunol. 2023. PMID: 36776895 Free PMC article. Review.
-
T-cell responses in asthma exacerbations.Ann Allergy Asthma Immunol. 2022 Dec;129(6):709-718. doi: 10.1016/j.anai.2022.07.027. Epub 2022 Jul 30. Ann Allergy Asthma Immunol. 2022. PMID: 35918022 Free PMC article. Review.
-
Mesenchymal stem cells alleviate LPS-induced acute lung injury by inhibiting the proinflammatory function of Ly6C+ CD8+ T cells.Cell Death Dis. 2020 Oct 6;11(10):829. doi: 10.1038/s41419-020-03036-1. Cell Death Dis. 2020. PMID: 33024074 Free PMC article.
-
Tnfaip3 expression in pulmonary conventional type 1 Langerin-expressing dendritic cells regulates T helper 2-mediated airway inflammation in mice.Allergy. 2020 Oct;75(10):2587-2598. doi: 10.1111/all.14334. Epub 2020 Jun 14. Allergy. 2020. PMID: 32329078 Free PMC article.
-
IL-15-deficient mice develop enhanced allergic responses to airway allergen exposure.Clin Exp Allergy. 2017 May;47(5):639-655. doi: 10.1111/cea.12886. Epub 2017 Feb 7. Clin Exp Allergy. 2017. PMID: 28093832 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
